INTRODUCTION: Previous studies have tested the hypothesis that calpain and/or proteasome inhibition is beneficial in Duchenne muscular dystrophy, based largely on evidence that calpain and proteasome activities are enhanced in the mdx mouse. METHODS: mRNA expression of ubiquitin-proteasome and calpain system components were determined using real-time polymerase chain reaction in skeletal muscle and heart in the golden retriever muscular dystrophy model. Similarly, calpain 1 and 2 and proteasome activities were determined using fluorometric activity assays. RESULTS: We found that less than half of the muscles tested had increases in proteasome activity, and only half had increased calpain activity. In addition, transcriptional regulation of the ubiquitin-proteasome system was most pronounced in the heart, where numerous components were significantly decreased. CONCLUSION: This study illustrates the diversity of expression and activities of the ubiquitin-proteasome and calpain systems, which may lead to unexpected consequences in response to pharmacological inhibition.
INTRODUCTION: Previous studies have tested the hypothesis that calpain and/or proteasome inhibition is beneficial in Duchenne muscular dystrophy, based largely on evidence that calpain and proteasome activities are enhanced in the mdxmouse. METHODS: mRNA expression of ubiquitin-proteasome and calpain system components were determined using real-time polymerase chain reaction in skeletal muscle and heart in the golden retriever muscular dystrophy model. Similarly, calpain 1 and 2 and proteasome activities were determined using fluorometric activity assays. RESULTS: We found that less than half of the muscles tested had increases in proteasome activity, and only half had increased calpain activity. In addition, transcriptional regulation of the ubiquitin-proteasome system was most pronounced in the heart, where numerous components were significantly decreased. CONCLUSION: This study illustrates the diversity of expression and activities of the ubiquitin-proteasome and calpain systems, which may lead to unexpected consequences in response to pharmacological inhibition.
Authors: S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass Journal: Science Date: 2001-10-25 Impact factor: 47.728
Authors: Joe N Kornegay; Diane D Cundiff; Daniel J Bogan; Janet R Bogan; Carol S Okamura Journal: Neuromuscul Disord Date: 2003-08 Impact factor: 4.296
Authors: B J Cooper; N J Winand; H Stedman; B A Valentine; E P Hoffman; L M Kunkel; M O Scott; K H Fischbeck; J N Kornegay; R J Avery Journal: Nature Date: 1988-07-14 Impact factor: 49.962
Authors: Gloria Bonuccelli; Federica Sotgia; William Schubert; David S Park; Philippe G Frank; Scott E Woodman; Luigi Insabato; Michael Cammer; Carlo Minetti; Michael P Lisanti Journal: Am J Pathol Date: 2003-10 Impact factor: 4.307
Authors: Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman Journal: Mamm Genome Date: 2012-01-05 Impact factor: 2.957
Authors: Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju Journal: ILAR J Date: 2014
Authors: Steven W Cotten; Joe N Kornegay; Daniel J Bogan; Kristine M Wadosky; Cam Patterson; Monte S Willis Journal: Am J Transl Res Date: 2013-12-01 Impact factor: 4.060
Authors: Karla P C Araujo; Gloria Bonuccelli; Caio N Duarte; Thais P Gaiad; Dayson F Moreira; David Feder; José E Belizario; Maria A Miglino; Michael P Lisanti; Carlos E Ambrosio Journal: PLoS One Date: 2013-04-08 Impact factor: 3.240